May 22, 2024 9:00am PDT, 11:00am CDT, 12:00pm EDT

Transforming DR-TB Detection with tNGS: Evidence, Cost Analysis, and Implementation Considerations

Sponsored by: Illumina
C.E. Credits: P.A.C.E. CE Florida CE

Event Date & Time

Broadcast 1:
Date: 22 May 2024 Asia/ Europe

9 AM - 10:30 AM (London)
10 AM - 11:30 AM (Cape Town/ Central Africa/ CEST) 
11 AM - 12:30 PM (Riyadh/ Istanbul)
1 PM - 2:30 PM (Islamabad)
12:30 PM - 2 PM (Kabul)
1:30 PM - 3 PM (New Delhi)
3 PM - 4:30 PM (Indonesia)
4 PM - 5:30 PM (Singapore/ Shanghai)
5 PM - 6.30 PM (Seoul/Tokyo)
6 PM - 7:30 PM (Melbourne)  

Broadcast 2:
Date: 22 May 2024 LATAM/ America

9 AM - 10:30 AM (Los Angeles)
11 AM - 12:30 PM (Peru)
12 PM - 1:30 PM (New York)
1 PM - 2:30 PM (Sao Paulo)

Join this webinar to learn from three accomplished leaders in the fight against TB:
Targeted NGS for Drug-resistant TB Detection: Evidence to Policy
Anita Suresh, Head of Genomics and Sequencing Unit, FIND, Geneva
Economic Analysis of Targeted NGS for Diagnosis of Drug-Resistant TB
Dr. Alice Zwerling, Associate Professor School of Epidemiology & Public Health, University of Ottawa, Canada
Practical Considerations for Implementing tNGS for DR-TB Detection in South Africa
Dr. Shaheed Vally Omar, Centre Head, Centre for Tuberculosis, National Institute for Communicable Disease, South Africa
Tuberculosis (TB) remains a leading global infectious disease killer, second only to COVID-19¹. It is an airborne disease caused by Mycobacterium tuberculosis bacteria and is responsible for infecting an estimated 10.6 million and killing 1.3 million people in 2022 alone¹. Gaps in detection and treatment of drug resistant TB (DR-TB) strains contribute to its continuation as a public health crisis¹. Targeted next-generation sequencing (tNGS) which provides comprehensive detection of DR-TB was recently recommended by WHO and can help address the gaps².
Learning Objectives
  • Discover studies and data demonstrating clinical accuracy, utility and cost effectiveness of tNGS for DR-TB detection. 
  • Understand critical operational factors for successful tNGS implementation at a national level. 
Webinars will be available for unlimited on-demand viewing after live event.


1. Global tuberculosis report 2022. Geneva: World Health Organization; 2022. License: CC BY-NC-SA 3.0 IGO.

2. WHO Rapid Communication: Use of targeted next-generation sequencing to detect drug-resistant tuberculosis. July 2023


Research Use Only. Not for use in diagnostic procedures. M-GL-02712

You May Also Like
Loading Comments...